CPHI 2026: Finding the right CDMO partner in an age of consolidation - Pharmaceutical Technology

Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing. Executives from companies such as Leo Pharma and Daiichi Sankyo debated outsourcing selections and whether size is better in manufacturing. A panel at CPHI discussed the consequences of ongoing manufacturing outsourcing M&A deals. Credit: DominicTyer/GlobalData. Consolidation among contract development and manufacturing organisations (CDMOs) has been a regular theme for the sector, given that scale is one area on which some firms seek to compete. Manufacturing outsourcing M&A deal volumes peaked in 2021 and, though the number of agreements has fallen…

Source: Pharmaceutical Technology